SC291

· Sana Biotechnology

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SC291, covering 2025-10-02 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]